Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC406

Enfortumab vedotin

  • Status:
    Veitt
  • Application date:
    3.10.2022
  • Application published:
    15.11.2022
  • Grant published:
    15.2.2025
  • Max expiry date:
    28.9.2036
  • Medicine name:
    Padcev
  • Medicine for children:
    No

Timeline

Today
3.10.2022Application
15.11.2022Publication
15.2.2025Registration
28.9.2036Expires

Marketing license

  • IS authorization number:
    EU/1/21/1615/001; EU/1/21/1615/002
  • Date:
    4.5.2022
  • Foreign authorization number:
    EU/1/21/1615
  • Date:
    13.4.2022

Owner

  • Name:
    Agensys, Inc.
  • Address:
    1 Astellas Way, Northbrook US
  • Name:
    Seagen Inc.
  • Address:
    21823 30th Drive, S.E., Bothell US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 11.01.2025

Upload documents